Scaling up cell & gene therapy manufacture for commercial supply by integration of a needle-to-needle supply chain into the CGCT manufacturing centre
Lead Participant:
CELL THERAPY CATAPULT LIMITED
Abstract
Awaiting Public Project Summary
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| CELL THERAPY CATAPULT LIMITED | £626,355 | £ 626,355 |
Participant |
||
| THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST |
People |
ORCID iD |
| Emma Kinsey (Project Manager) |